Clinical Trial Update: Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

View source ↗

Summary

A completed clinical trial assesses whether a test reflecting immunological remission can predict discontinuation of abatacept in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Rheumatoid Arthritis | Status: COMPLETED